Morgan Stanley Maintains Overweight on MetLife, Raises Price Target to $103

Benzinga Newsdesk www.benzinga.com Positive 74.7%

Neg 0% Neu 0% Pos 74.7%

Morgan Stanley analyst Nigel Dally maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $93 to $103.